Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Proof of Concept, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Subjects With Nonalcoholic Steatohepatitis (NASH)

NCT03987074 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT03987074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03987074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Proof of Concept, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Subjects With Nonalcoholic Steatohepatitis (NASH)
Lead sponsor
Gilead Sciences
Phase
Phase 2
Overall status
Completed
Start date
July 29, 2019
Completion date
July 13, 2020
Enrollment
109 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

nonalcoholic steatohepatitis